Skip to main navigation
Skip to search
Skip to main content
Research @ Flinders Home
Search content at Research @ Flinders
Home
Profiles
Research Units
Research Outputs
Projects
Student theses
Activities
Prizes
Equipment
Treatment for peritoneal dialysis-associated peritonitis
Angela E. Ballinger
, Suetonia C. Palmer
, Kathryn J. Wiggins
,
Jonathan C. Craig
, David W. Johnson
, Nicholas B. Cross
, Giovanni F.M. Strippoli
Research output
:
Contribution to journal
›
Review article
›
peer-review
42
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Treatment for peritoneal dialysis-associated peritonitis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Peritonitis
100%
Peritoneal Dialysis
100%
Antimicrobial Agent
45%
Catheter Removal
45%
Antibiotics
36%
Antiinfective Agent
27%
Randomized Controlled Trial
27%
Glycopeptide
27%
Urokinase
27%
Morbidity
18%
Recurrence Risk
18%
Vancomycin
18%
Recurrent Disease
9%
Treatment Response
9%
Immunoglobulin G1
9%
Intraperitoneal Drug Administration
9%
Thrombolytic Drug
9%
Hemodialysis
9%
Random Effects Model
9%
Teicoplanin
9%
Treatment Duration
9%
Dialysis Catheter
9%
Gentamicin
9%
First Generation Cephalosporin
9%
Oral
9%
Pharmacology, Toxicology and Pharmaceutical Science
Peritonitis
100%
Antimicrobial Agent
45%
Antibiotics
36%
Randomized Controlled Trial
27%
Antiinfective Agent
27%
Urokinase
27%
Glycopeptide
27%
Antibiotic Agent
18%
Recurrence Risk
18%
Morbidity
18%
Vancomycin
18%
Random Effects Model
9%
Gentamicin
9%
Ototoxicity
9%
First Generation Cephalosporin
9%
Recurrent Disease
9%
Hemodialysis
9%
Immunoglobulin G1
9%
Fibrinolytic Agent
9%
Teicoplanin
9%